A Randomized, Double-Blind, Phase 3 Trial of Dapagliflozin Add-on to Saxagliptin plus Metformin in Type 2 Diabetes

被引：0
|
作者：
Mathieu, Chantal
Ranetti, Aurelian E.
Li, Danshi
Ekholm, Ella
Cook, William
Hirshberg, Boaz
Hansen, Lars
Iqbal, Nayyar
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105-OR
引用
收藏
页码：A28 / A28
页数：1
相关论文
共 50 条
  • [1] A randomised, double-blind phase 3 trial of dapagliflozin add-on to saxagliptin plus metformin in type 2 diabetes
    Mathieu, C.
    Ranetti, A. E.
    Li, D.
    Ekholm, E.
    Cook, W.
    Hirshberg, B.
    Hansen, L.
    Iqbal, N.
    DIABETOLOGIA, 2015, 58 : S356 - S356
  • [2] A Randomized, Double-Blind Trial of Saxagliptin Add-on to Dapagliflozin plus Metformin
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    Hansen, Lars
    DIABETES, 2015, 64 : A27 - A28
  • [3] Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian Emil
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Hansen, Lars
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (11) : 2009 - 2017
  • [4] Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Chen, Hungta
    Iqbal, Nayyar
    Hansen, Lars
    DIABETES CARE, 2015, 38 (11) : 2018 - 2024
  • [5] A randomised, double-blind trial of saxagliptin add-on to dapagliflozin plus metformin
    Catrinoiu, D.
    Matthaei, S.
    Celinski, A.
    Ekholm, E.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Hansen, L.
    DIABETOLOGIA, 2015, 58 : S386 - S386
  • [6] Randomised, double-blind trial of dual add-on saxagliptin plus dapagliflozin vs saxagliptin or dapagliflozin add-on alone in poorly controlled type 2 diabetes on metformin
    Hansen, L.
    Zee, P.
    Li, Y.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Rosenstock, J.
    DIABETOLOGIA, 2014, 57 : S8 - S8
  • [7] Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
    Rosenstock, Julio
    Hansen, Lars
    Zee, Pamela
    Li, Yan
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    DIABETES CARE, 2015, 38 (03) : 376 - 383
  • [8] Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes
    Mueller-Wieland, Dirk
    Kellerer, Monika
    Cypryk, Katarzyna
    Skripova, Dasa
    Rohwedder, Katja
    Johnsson, Eva
    Garcia-Sanchez, Ricardo
    Kurlyandskaya, Raisa
    Sjostrom, C. David
    Jacob, Stephan
    Seufert, Jochen
    Dronamraju, Nalina
    Csomos, Katalin
    DIABETES OBESITY & METABOLISM, 2018, 20 (11): : 2598 - 2607
  • [9] Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes
    Frias, Juan P.
    Gonzalez-Galvez, Guillermo
    Johnsson, Eva K.
    Maaske, Jill
    Peters, Anne
    DIABETES, 2018, 67
  • [10] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Clifford J Bailey
    Jorge L Gross
    Delphine Hennicken
    Nayyar Iqbal
    Traci A Mansfield
    James F List
    BMC Medicine, 11
12345